Established in 1987 as the Aids Clinical Trials Unit (ACTU), the Washington University ACTU has been a highly productive participant in the AIDS Clinical Trials Group and is funded by the National Institute of Allergy and Infectious Diseases. Centrally located in the Midwest, it draws participants from Missouri, Illinois, Arkansas, Kansas, Tennessee, Nebraska and Oklahoma. Within the Division of Infectious Diseases, this ACTU is considered among the finest in the world.
The Washington University Infectious Diseases Clinical Research Unit (ID-CRU), as it is now known, is highly regarded for their expertise and is well established in the community. Led by Rachel Presti, MD, PhD, the ID-CRU provides access to HIV and Infectious Disease research opportunities, community outreach and education.
Team
Aditi Ramakrishnan, MD, MSc
Assistant Professor of Medicine
- Email: aditir@wustl.edu
Dr. Ramakrishnan’s research focuses on applying implementation science strategies to improve domestic HIV prevention and care, particularly for cisgender women.
Adriana M. Rauseo, MD, FIDSA
Assistant Professor of Medicine
- Phone: 314-454-8254
- Email: a.rauseoacevedo@wustl.edu
Dr. Rauseo specializes in clinical infectious diseases, with a special focus on mycology and infectious that affect immunocompromised hosts. Since the outset of the COVID-19 pandemic she has served as an investigator in the Infectious Disease Clinical Research Unit (ID-CRU) in multiple clinical trials and translational research in the fight against COVID-19.
